2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions

View by Date

Sunday, October 21, 2018

9:00AM-11:00AM: Antiphospholipid Syndrome Poster

9:00AM-11:00AM: B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

9:00AM-11:00AM: Education Poster

9:00AM-11:00AM: Epidemiology and Public Health Poster I – ARHP

9:00AM-11:00AM: Epidemiology and Public Health Poster I: Rheumatoid Arthritis

9:00AM-11:00AM: Fibromyalgia and Other Clinical Pain Syndromes Poster

9:00AM-11:00AM: Fibromyalgia and Other Clinical Pain Syndromes Poster – ARHP

9:00AM-11:00AM: Health Services Research Poster I – ACR/ARHP

9:00AM-11:00AM: Healthcare Disparities in Rheumatology Poster

9:00AM-11:00AM: Healthcare Disparities in Rheumatology Poster – ARHP

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster I – ARHP

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster I: MRI

9:00AM-11:00AM: Measures and Measurement of Healthcare Quality Poster I

9:00AM-11:00AM: Measures and Measurements of Healthcare Quality Poster – ARHP

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster I: Checkpoint Inhibitors, Retroperitoneal Fibrosis

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies Poster – ARHP

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies Poster I: Clinical Features and Disease Course

9:00AM-11:00AM: Orthopedics, Low Back Pain and Rehabilitation Poster – ACR/ARHP

9:00AM-11:00AM: Osteoarthritis – Clinical Poster I

9:00AM-11:00AM: Pain Mechanisms – Basic and Clinical Science Poster

9:00AM-11:00AM: Pain Mechanisms – Basic and Clinical Science Poster – ARHP

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster I: Lupus, Sjögren’s Disease, and Myositis

9:00AM-11:00AM: Rheumatoid Arthritis – Animal Models Poster

9:00AM-11:00AM: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities

9:00AM-11:00AM: Rheumatoid Arthritis – Etiology and Pathogenesis Poster I

9:00AM-11:00AM: Rheumatoid Arthritis – Treatments Poster I – ARHP

9:00AM-11:00AM: Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

9:00AM-11:00AM: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster I

9:00AM-11:00AM: Systemic Sclerosis and Related Disorders – Basic Science Poster I

9:00AM-11:00AM: Systemic Sclerosis and Related Disorders – Clinical Poster I

9:00AM-11:00AM: T Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

9:00AM-11:00AM: Vasculitis Poster I: Non-ANCA-Associated and Related Disorders

11:00AM-12:30PM: 3S037 ACR Abstract: Plenary Session I (835–839)

12:00PM-2:00PM: 3S041 ACR/ARHP: Patient Perspectives Poster Session

2:30PM-4:00PM: 3S079 ACR Abstract: Antiphospholipid Syndrome (851–856)

2:30PM-4:00PM: 3S080 ACR Abstract: Cytokines & Cell Trafficking (840–845)

2:30PM-4:00PM: 3S081 ACR Abstract: Education (857–862)

2:30PM-4:00PM: 3S082 ACR Abstract: Imaging of Rheumatic Diseases I: MRI & CT (863–868)

2:30PM-4:00PM: 3S083 ACR Abstract: Metabolic & Crystal Arthropathies: Comorbidities & Outcomes (869–874)

2:30PM-4:00PM: 3S084 ACR Abstract: Muscle Biology, Myositis & Myopathies I: Biomarkers (875–879)

2:30PM-4:00PM: 3S085 ACR Abstract: Osteoarthritis & Joint Biology–Basic Science (846–850)

2:30PM-4:00PM: 3S086 ACR Abstract: RA–DX, Manifestations, & Outcomes I: Other Co-Morbidities (880–885)

2:30PM-4:00PM: 3S087 ACR Abstract: RA–Treatments I: JAK Inhibitors (886–891)

2:30PM-4:00PM: 3S088 ACR Abstract: Spondyloarthritis Incl PsA–Clinical I: Axial SpA Epidemiology (892–897)

2:30PM-4:00PM: 3S089 ACR Abstract: Systemic Sclerosis & Rel D/O–Clinical I: Clinical Trials I (898–903)

2:30PM-4:00PM: 3S090 ACR Abstract: Vasculitis–ANCA-Assocd (904–909)

2:30PM-4:00PM: 3S093 ACR/ARHP Abstract: Epidemiology & Pub Health (910–915)

4:30PM-6:00PM: 3S102 ACR Abstract: Epidemiology & Pub Health I: Morbidity & Mortality (940–945)

4:30PM-6:00PM: 3S103 ACR Abstract: Genetics, Genomics & Proteomics: Precision Medicine (916–921)

4:30PM-6:00PM: 3S104 ACR Abstract: Infection-Related Rheumatic Disease (946–951)

4:30PM-6:00PM: 3S105 ACR Abstract: Osteoarthritis–Clinical (952–957)

4:30PM-6:00PM: 3S106 ACR Abstract: Pediatric Rheumatology–Basic Science (922–927)

4:30PM-6:00PM: 3S107 ACR Abstract: RA–Etiology & Pathogenesis I (928–933)

4:30PM-6:00PM: 3S108 ACR Abstract: RA–Treatments II: Safety (958–963)

4:30PM-6:00PM: 3S109 ACR Abstract: SLE–Animal Models (934–939)

4:30PM-6:00PM: 3S110 ACR Abstract: SLE–Clinical I: Clinical Trials (970–975)

4:30PM-6:00PM: 3S111 ACR Abstract: Spondyloarthritis Incl PsA–Clinical II: PsA Epidemiology (964–969)

4:30PM-6:00PM: 3S115 ACR/ARHP Abstract: Pediatric Rheum (976–981)

Monday, October 22, 2018

9:00AM-11:00AM: Cytokines and Cell Trafficking Poster

9:00AM-11:00AM: Epidemiology and Public Health Poster II – ARHP

9:00AM-11:00AM: Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function

9:00AM-11:00AM: Health Services Research Poster II – ACR/ARHP

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster II – ARHP

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster II: Ultrasound

9:00AM-11:00AM: Infection-related Rheumatic Disease Poster

9:00AM-11:00AM: Infection-related Rheumatic Disease Poster – ARHP

9:00AM-11:00AM: Innate Immunity Poster

9:00AM-11:00AM: Measures and Measurement of Healthcare Quality Poster II

9:00AM-11:00AM: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster I

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster II: Interstitial Lung Disease, Still's Disease, FMF, Polychondritis

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies Poster II: Basic and Translational Science

9:00AM-11:00AM: Osteoarthritis – Clinical Poster – ARHP

9:00AM-11:00AM: Osteoarthritis – Clinical Poster II

9:00AM-11:00AM: Osteoarthritis and Joint Biology – Basic Science Poster I

9:00AM-11:00AM: Patient Outcomes, Preferences, and Attitudes Poster I – ARHP

9:00AM-11:00AM: Patient Outcomes, Preferences, and Attitudes Poster I: Patient-Reported Outcomes

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster I – ARHP

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster II: Autoinflammatory Disorders, Scleroderma, and Miscellaneous

9:00AM-11:00AM: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis

9:00AM-11:00AM: Rheumatoid Arthritis – Diagnosis, Manifestions, and Outcomes Poster – ARHP

9:00AM-11:00AM: Rheumatoid Arthritis – Etiology and Pathogenesis Poster II

9:00AM-11:00AM: Rheumatoid Arthritis – Treatments Poster II – ARHP

9:00AM-11:00AM: Rheumatoid Arthritis – Treatments Poster II: PROs, Safety and Comorbidity

9:00AM-11:00AM: Sjögren's Syndrome – Basic and Clinical Science Poster

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster – ARHP

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Poster – ARHP

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Poster II: Biomarkers and Outcomes

9:00AM-11:00AM: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster II

9:00AM-11:00AM: Systemic Sclerosis and Related Disorders – Basic Science Poster II

9:00AM-11:00AM: Systemic Sclerosis and Related Disorders – Clinical Poster II

9:00AM-11:00AM: Vasculitis – ANCA-Associated Poster I

9:00AM-11:00AM: Vasculitis Poster II: Behҫet’s Disease and IgG4-Related Disease

11:00AM-12:30PM: 4M042 ACR Abstract: Plenary Session II (1816–1821)

2:30PM-4:00PM: 4M081 ACR Abstract: Edmond L. Dubois, MD Memorial Lecture: SLE–Clinical (1870–1874)

2:30PM-4:00PM: 4M082 ACR Abstract: Fibromyalgia & Other Clinical Pain Syndromes (1834–1839)

2:30PM-4:00PM: 4M083 ACR Abstract: Healthcare Disparities in Rheumatology (1840–1845)

2:30PM-4:00PM: 4M084 ACR Abstract: Pediatric Rheum–Clinical I: Outcomes & Comorbidities (1846–1851)

2:30PM-4:00PM: 4M085 ACR Abstract: RA–Animal Models (1822–1827)

2:30PM-4:00PM: 4M086 ACR Abstract: RA–DX, Manifestations, & Outcomes II: DX & Prognosis I (1858–1863)

2:30PM-4:00PM: 4M087 ACR Abstract: Reproductive Issues in Rheumatic Disorders (1852–1857)

2:30PM-4:00PM: 4M088 ACR Abstract: Spondyloarthritis Incl PsA–Basic Science (1828–1833)

2:30PM-4:00PM: 4M089 ACR Abstract: Spondyloarthritis Incl PsA–Clinical III: Treatment of Axial SpA (1864–1869)

2:30PM-4:00PM: 4M090 ACR Abstract: Systemic Sclerosis & Rel D/O–Clinical II: Clinical Trials II (1875–1880)

2:30PM-4:00PM: 4M091 ACR Abstract: Vasculitis–Non-ANCA-Assocd & Rel D/Os I: Population-Based Studies(1881–1886)

2:30PM-4:00PM: 4M094 ACR/ARHP Abstract: Health Services Research I: Focus on Big Data (1887–1892)

4:30PM-6:00PM: 4M101 ACR Abstract: Epidemiology & Pub Health II: RA Risk: Education, Obesity, Smoking, or Biomarkers? (1905–1910)

4:30PM-6:00PM: 4M102 ACR Abstract: Misc Rheum & Inflam DZ I: DADA2, Cardiac Sarcoid,Cancer Immunotherapy(1911–1916)

4:30PM-6:00PM: 4M103 ACR Abstract: Pain Mechanisms–Basic & Clinical Science (1917–1922)

4:30PM-6:00PM: 4M104 ACR Abstract: Patient Outcomes, Preferences, & Attitudes I: Beliefs & Behaviors (1923–1928)

4:30PM-6:00PM: 4M105 ACR Abstract: RA–DX, Manifestations, & Outcomes III: Diagnosis & Prognosis II (1929–1934)

4:30PM-6:00PM: 4M106 ACR Abstract: RA–Treatments III: New Compounds & Biosimilars (1935–1940)

4:30PM-6:00PM: 4M107 ACR Abstract: SLE–Clinical II: Renal & Neuropsychiatric Disease in SLE (1941–1945)

4:30PM-6:00PM: 4M108 ACR Abstract: SLE–Etiology & Pathogenesis I (1893–1898)

4:30PM-6:00PM: 4M109 ACR Abstract: Systemic Sclerosis & Rel D/Os–Basic Science (1899–1904)

4:30PM-6:00PM: 4M114 ACR/ARHP Abstract: Orthopedics, Low Back Pain & Rehabilitation (1952–1957)

4:30PM-6:00PM: 4M117 ARHP Abstract: Pain, Anxiety, & Depression–ARHP I (1946–1951)

Tuesday, October 23, 2018

9:00AM-11:00AM: Epidemiology and Public Health Poster III – ARHP

9:00AM-11:00AM: Epidemiology and Public Health Poster III: SLE, SSc, APS, PsA, and Other Rheumatic Diseases

9:00AM-11:00AM: Genetics, Genomics and Proteomics Poster

9:00AM-11:00AM: Health Services Research Poster III – ACR/ARHP

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster III: Other Modalities

9:00AM-11:00AM: Late-Breaking Abstract Poster Session

9:00AM-11:00AM: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster II

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster – ARHP

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster III: Sarcoid, Inflammatory Eye Disease, and Autoinflammatory Disease

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies Poster III: Treatment and Classification Criteria

9:00AM-11:00AM: Osteoarthritis and Joint Biology – Basic Science Poster II

9:00AM-11:00AM: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

9:00AM-11:00AM: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster – ARHP

9:00AM-11:00AM: Patient Outcomes, Preferences, and Attitudes Poster II – ARHP

9:00AM-11:00AM: Patient Outcomes, Preferences, and Attitudes Poster II: Patient Perspectives

9:00AM-11:00AM: Pediatric Rheumatology – Basic Science Poster

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster II – ARHP

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster III: Juvenile Idiopathic Arthritis and Uveitis

9:00AM-11:00AM: Reproductive Issues in Rheumatic Disorders Poster

9:00AM-11:00AM: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster III: Complications of Therapy, Outcomes, and Measures

9:00AM-11:00AM: Rheumatoid Arthritis – Etiology and Pathogenesis Poster III

9:00AM-11:00AM: Rheumatoid Arthritis – Treatments Poster III: Biosimilars and New Compounds

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster III: Treatment

9:00AM-11:00AM: Systemic Lupus Erythematosus – Animal Models Poster

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Poster III: Treatment

9:00AM-11:00AM: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster III

9:00AM-11:00AM: Systemic Sclerosis and Related Disorders – Clinical Poster III

9:00AM-11:00AM: Vasculitis – ANCA-Associated Poster II

9:00AM-11:00AM: Vasculitis Poster III: Immunosuppressive Therapy in Giant Cell Arteritis and Polymyalgia Rheumatica

11:00AM-12:30PM: 5T046 ACR Abstract: Plenary Session III (2785–2790)

2:30PM-4:00PM: 5T085 ACR Abstract: B Cell Biology & Targets in Autoimmune & Inflammatory Disease (2791–2796)

2:30PM-4:00PM: 5T086 ACR Abstract: Epidemiology & Pub Health III: SLE & SSc, Big Data & Large Cohorts (2802–2807)

2:30PM-4:00PM: 5T087 ACR Abstract: Osteoporosis & Metabolic Bone Disease–Basic & Clinical Science (2808–2813)

2:30PM-4:00PM: 5T088 ACR Abstract: RA–DX, Manifestations, & Outcomes IV: CV Co-Morbidities (2814–2819)

2:30PM-4:00PM: 5T089 ACR Abstract: RA–Treatments IV: Strategy (2820–2825)

2:30PM-4:00PM: 5T090 ACR Abstract: SLE–Clinical III: Translational Aspects (2832–2837)

2:30PM-4:00PM: 5T091 ACR Abstract: Spondyloarthritis Incl PsA–Clinical IV: Comorbid/Related Conditions(2826–2831)

2:30PM-4:00PM: 5T092 ACR Abstract: T Cell Biology & Targets in Autoimmune & Inflammatory Disease (2797–2801)

2:30PM-4:00PM: 5T093 ACR Abstract: Vasculitis–Non-ANCA-Assocd & Rel D/Os II: Novel Diagnostics & THRs (2838–2843)

2:30PM-4:00PM: 5T099 ARHP Abstract: Clinical Aspects & Outcomes Research–ARHP II (2844–2849)

4:00PM-6:00PM: 5T113 Abstracts: Late-Breaking Abstract Session

4:30PM-6:00PM: 5T105 ACR Abstract: Innate Immunity (2850–2855)

4:30PM-6:00PM: 5T106 ACR Abstract: Measures of Healthcare Quality I: QI in RA (2856–2861)

4:30PM-6:00PM: 5T107 ACR Abstract: Pediatric Rheum–Clinical II: Treatment Update (2862–2867)

4:30PM-6:00PM: 5T108 ACR Abstract: RA–DX, Manifestations, & Outcomes V: Outcomes Measures (2868–2873)

4:30PM-6:00PM: 5T109 ACR Abstract: RA–Treatments V: Beyond Individual Compounds (2874–2879)

4:30PM-6:00PM: 5T110 ACR Abstract: Sjögren's Syndrome–Basic & Clinical Science (2880–2885)

4:30PM-6:00PM: 5T111 ACR Abstract: SLE–Clinical IV: Clinical Outcomes (2892–2897)

4:30PM-6:00PM: 5T112 ACR Abstract: Spondyloarthritis Incl PsA–Clinical V: Tx of PsA & Peripheral SpA (2886–2891)

Wednesday, October 24, 2018

9:00AM-10:30AM: 6W006 ACR Abstract: Imaging of Rheumatic Diseases II: Ultrasound (2904–2909)

9:00AM-10:30AM: 6W007 ACR Abstract: Patient Outcomes, Preferences, & Attitudes II: PROs (2910–2915)

9:00AM-10:30AM: 6W008 ACR Abstract: Pediatric Rheum–Clinical III: Assessment Tools & Biomarkers (2916–2921)

9:00AM-10:30AM: 6W009 ACR Abstract: RA–Etiology & Pathogenesis II (2898–2903)

9:00AM-10:30AM: 6W010 ACR Abstract: SLE–Clinical V: Biomarkers, Criteria, & Outcomes (2928–2933)

9:00AM-10:30AM: 6W011 ACR Abstract: Spondyloarthritis Incl PsA–Clinical VI: Imaging of Axial SpA (2922–2927)

9:00AM-10:30AM: 6W012 ACR Abstract: Systemic Sclerosis & Rel D/O III:Cohort Study, Biomarkers, & Response(2934–2939)

9:00AM-10:30AM: 6W016 ARHP Abstract: Interventions & Self-Management–ARHP III (2940–2945)

11:00AM-12:30PM: 6W018 ACR Abstract: Epidemiology & Pub Health IV: Determinants & Consequences of Tx (2952–2957)

11:00AM-12:30PM: 6W019 ACR Abstract: Measures of Healthcare Quality II: QI in SLE, Gout & JIA (2958–2963)

11:00AM-12:30PM: 6W020 ACR Abstract: Metabolic & Crystal Arthropathies–Basic Science & Imaging (2964–2969)

11:00AM-12:30PM: 6W021 ACR Abstract: Misc Rheumatic & Inflam DZ II (2970–2975)

11:00AM-12:30PM: 6W022 ACR Abstract: Muscle Biology, Myositis & Myopathies II: Clinical & Misc Topics (2976–2981)

11:00AM-12:30PM: 6W023 ACR Abstract: RA–DX, Manifestations, & Outcomes VI: Outcomes Reports (2982–2987)

11:00AM-12:30PM: 6W024 ACR Abstract: SLE–Etiology & Pathogenesis II (2946–2951)

11:00AM-12:30PM: 6W025 ACR Abstract: Vasculitis–Non-ANCA-Assocd & Rel D/Os III: Clinical Subtype & Outcome(2988–2993)

11:00AM-12:30PM: 6W027 ACR/ARHP Abstract: Health Services Research II: Economic & Clinical Implications (2994–2999)